Latigo taps Farzan for CEO post
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks biotech company appoints CEO
Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, announced that it has appointed Nima Farzan to be its CEO. Announced July 22, Farzan brings a “strong track record” with more than two decades of leadership experience in the biopharmaceutical industry. Farzan is also Latigo’s first CEO as he replaces Desmond Padhi, operating partner Read More →
Conejo Valley biotech’s passage to India
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Novocuff raises $26M to address preterm births
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Takeda gives life to Moorpark biolab
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The Nexstera big thing
What started as a year-long senior project at Cal Poly San Luis Obispo could turn out to be a lifelong passion for Penny Lane Case and her fellow co-founders of Nexstera Tech. Nexstera, founded in 2022, is a startup with a lot of momentum. The goal of the company is to help mitigate the risk of waste fires started Read More →
